Cardinal Health will put up a cool $1.49 billion to purchase Cordis from Johnson & Johnson. Cordis focuses on creating medical devices, specifically stents and catheters.
With the addition of Cordis, Cardinal Health increases its inventory of products for sale to hospitals, ASCs and physicians.
Don Casey, head of Cardinal’s medical segment stated,”As we bring more of these strategies to bear, that’s going to make us increasingly important to hospitals.
The deal is expected to close close to the end of the year.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.